Avacta Group Plc Stock London S.E.
Equities
GB0033519546
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
Apr. 22 | First Tin updates Tellerhauser estimates | AN |
Apr. 10 | Transcript : Avacta Group Plc - Special Call |
Sales 2023 * | 23.08M 28.84M | Sales 2024 * | 26.12M 32.63M | Capitalization | 173M 217M |
---|---|---|---|---|---|
Net income 2023 * | -23M -28.73M | Net income 2024 * | -32M -39.97M | EV / Sales 2023 * | 6.81 x |
Net cash position 2023 * | 16.2M 20.24M | Net cash position 2024 * | 7.3M 9.12M | EV / Sales 2024 * | 6.36 x |
P/E ratio 2023 * |
-5.88
x | P/E ratio 2024 * |
-4.32
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 70.66% |
Latest transcript on Avacta Group Plc
Managers | Title | Age | Since |
---|---|---|---|
Alastair Smith
FOU | Founder | - | 03-12-31 |
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 16-01-03 |
Matt Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 13-09-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Nicholls
BRD | Director/Board Member | 67 | 13-08-01 |
Alastair Smith
FOU | Founder | - | 03-12-31 |
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 16-01-03 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |